These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 7503805)

  • 1. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver.
    Prueksaritanont T; Dwyer LM; Cribb AE
    Biochem Pharmacol; 1995 Oct; 50(9):1521-5. PubMed ID: 7503805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6.
    Mankowski DC
    Drug Metab Dispos; 1999 Sep; 27(9):1024-8. PubMed ID: 10460802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
    Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.
    Li Y; Li NY; Sellers EM
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):295-304. PubMed ID: 9512924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells.
    Prueksaritanont T; Gorham LM; Hochman JH; Tran LO; Vyas KP
    Drug Metab Dispos; 1996 Jun; 24(6):634-42. PubMed ID: 8781778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes.
    Mimura M; Yamazaki H; Sugahara C; Hiroi T; Funae Y; Shimada T
    Biochem Pharmacol; 1994 Jun; 47(11):1957-63. PubMed ID: 7912070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes.
    Takemoto K; Yamazaki H; Tanaka Y; Nakajima M; Yokoi T
    Xenobiotica; 2003 Jan; 33(1):43-55. PubMed ID: 12519693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems.
    Halliday RC; Jones BC; Smith DA; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1995 Oct; 40(4):369-78. PubMed ID: 8554939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic specificity of CYP2D isoforms in rat and human.
    Hiroi T; Chow T; Imaoka S; Funae Y
    Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in man.
    Zanger UM; Vilbois F; Hardwick JP; Meyer UA
    Biochemistry; 1988 Jul; 27(15):5447-54. PubMed ID: 3052575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary DNA cloning and characterization of cytochrome P450 2D29 from Japanese monkey liver.
    Hichiya H; Takemi C; Tsuzuki D; Yamamoto S; Asaoka K; Suzuki S; Satoh T; Shinoda S; Kataoka H; Narimatsu S
    Biochem Pharmacol; 2002 Oct; 64(7):1101-10. PubMed ID: 12234613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450IID subfamily in non-human primates. Catalytical and immunological characterization.
    Jacqz-Aigrain E; Gueguen M; Zanger UM; Robieux I; Alvarez F
    Biochem Pharmacol; 1991 Jun; 41(11):1657-63. PubMed ID: 2043154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism in drug oxidation: in vitro studies of human debrisoquine 4-hydroxylase and bufuralol 1'-hydroxylase activities.
    Boobis AR; Murray S; Hampden CE; Davies DS
    Biochem Pharmacol; 1985 Jan; 34(1):65-71. PubMed ID: 3966916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes.
    Hashizume T; Imaoka S; Mise M; Terauchi Y; Fujii T; Miyazaki H; Kamataki T; Funae Y
    J Pharmacol Exp Ther; 2002 Jan; 300(1):298-304. PubMed ID: 11752129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of a cytochrome P4502D subfamily in human liver microsomal bunitrolol 4-hydroxylation.
    Narimatsu S; Masubuchi Y; Hosokawa S; Ohmori S; Kitada M; Suzuki T
    Biol Pharm Bull; 1994 Jun; 17(6):803-7. PubMed ID: 7951142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselectivity in the oxidation of bufuralol, a chiral substrate, by human cytochrome P450s.
    Narimatsu S; Takemi C; Kuramoto S; Tsuzuki D; Hichiya H; Tamagake K; Yamamoto S
    Chirality; 2003 May; 15(4):333-9. PubMed ID: 12666241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.
    Chow T; Imaoka S; Hiroi T; Funae Y
    Drug Metab Dispos; 1999 Feb; 27(2):188-92. PubMed ID: 9929501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of antiparasitic drugs on cytochrome P450 2D6.
    Masimirembwa CM; Hasler JA; Johansson I
    Eur J Clin Pharmacol; 1995; 48(1):35-8. PubMed ID: 7621845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 is the principal cytochrome P450 responsible for metabolism of the histamine H1 antagonist promethazine in human liver microsomes.
    Nakamura K; Yokoi T; Inoue K; Shimada N; Ohashi N; Kume T; Kamataki T
    Pharmacogenetics; 1996 Oct; 6(5):449-57. PubMed ID: 8946477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.